SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-013498
Filing Date
2022-07-29
Accepted
2022-07-29 16:01:14
Documents
15
Period of Report
2022-07-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20220725.htm   iXBRL 8-K 73095
2 EX-10.1 gls-ex10_1.htm EX-10.1 81563
3 EX-10.2 gls-ex10_2.htm EX-10.2 89102
  Complete submission text file 0000950170-22-013498.txt   425362

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20220725_lab.xml EX-101.LAB 17341
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20220725.xsd EX-101.SCH 3090
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20220725_pre.xml EX-101.PRE 12973
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20220725_def.xml EX-101.DEF 13673
9 EXTRACTED XBRL INSTANCE DOCUMENT gls-20220725_htm.xml XML 6596
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 221120695
SIC: 2834 Pharmaceutical Preparations